Category: Cell
-
Why gene therapy for sickle cell is slow to catch on with patients By Reuters
•
Written by Dina Beasley LOS ANGELES (Reuters) – Student Zoe Davis, 20, was just weeks into her first year of school when she returned to the hospital with severe sickle cell pain earlier this month. She does what she can to prevent the bouts of paralysis in her arms, legs…
-
Why gene therapy for sickle cell is slow to catch on with patients By Reuters
•
Written by Dina Beasley LOS ANGELES (Reuters) – Student Zoe Davis, 20, was just weeks into her first year of school when she returned to the hospital with severe sickle cell pain earlier this month. She does what she can to prevent the bouts of paralysis in her arms, legs…
-
FBI seizes Republican Representative Ogles’ cell phone in funding probe By Reuters
•
WASHINGTON (Reuters) – Republican U.S. Representative Andy Ogles said on Tuesday that FBI agents seized his cellphone as part of an investigation into problems surrounding his disclosure of campaign funds. “Last Friday, the FBI seized my cell phone,” Ogles said in a statement posted to X, formerly known as Twitter.…
-
CALQUENCE ® (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial
•
First and only BTK inhibitor to demonstrate favorable overall survival trend vs. standard-of-care chemoimmunotherapy in this setting WILMINGTON, Del.–(BUSINESS WIRE)–Positive results from the ECHO Phase III trial showed AstraZeneca (NASDAQ:)’s CALQUENCE ® (acalabrutinib) in combination with bendamustine and rituximab demonstrated a statistically significant and clinically meaningful improvement in progression-free survival…
-
NMDP BioTherapies To Present Data at ISCT 2024 on the Stability of Infectious Disease Marker Analytes During Donor Qualification for Allogeneic Cell Therapies
•
Article content The study, jointly conducted by researchers from Labor Quade and Johns Hopkins University School of Medicine, analyzed the long-term stability of IDM analytes in non-centrifuged peripheral blood samples to allow for increased flexibility in processing donor samples. The study results indicate that the widespread use of blood processing…